KKR Acquires European Healthcare Platform in $12B Deal

The acquisition of MedVista Group represents KKR's largest European healthcare transaction and one of the firm's top five global deals by enterprise value. MedVista operates 420 clinics and 38 hospitals across Germany, France, the Netherlands, and Scandinavia, generating approximately €3.2 billion in annual revenue.

Deal Structure and Financing

KKR is acquiring MedVista from a consortium of sellers including CVC Capital Partners, which held a controlling stake since 2020, and the founding Lindqvist family, which will retain a 12% minority interest. The deal includes approximately $5.8 billion in equity from KKR's European Fund VI and $6.2 billion in debt financing arranged by Goldman Sachs, Deutsche Bank, and BNP Paribas.

The 14.5x EBITDA multiple represents a premium to recent European healthcare transactions, which have averaged 11-13x, reflecting MedVista's market position and organic growth trajectory of 8-10% annually.

Strategic Rationale

KKR plans to accelerate MedVista's expansion into underserved markets in Southern and Eastern Europe while investing in digital health capabilities. The firm has identified €200-300 million in potential bolt-on acquisitions within the first 18 months post-close.

European private healthcare has become an increasingly attractive sector for PE investors as public systems face capacity constraints and aging demographics drive demand. KKR's healthcare portfolio globally now exceeds $25 billion in aggregate enterprise value across 15 platform companies.